{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors", "item": "https://www.patentleaderboard.com/patent/12258389"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors

Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors

US Patent 12258389 · Granted Mar 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Self-assembling synthetic proteins comprising cholera toxin beta subunit2025
Methods and compositions for inhibition of EGF/EGFR pathway in combination with 2025
Synthetic proteins and therapeutic uses thereof2024
Recombinant proteins and their therapeutic uses2024
Self-assembling synthetic proteins2022
Recombinant proteins and their therapeutic uses2021
Epidermal growth factor fusion proteins with mutant cholera toxin B subunits2020
Process for producing influenza vaccine2019
Recombinant proteins and their therapeutic uses2018
Process for producing influenza vaccine2017
Composition2007
Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents2002